Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

被引:228
作者
Parker, Alan L.
Waddington, Simon N.
Nicol, Campbell G.
Shayakhmetov, Dmitry M.
Buckley, Suzanne M.
Denby, Laura
Kemball-Cook, Geoffrey
Ni, Shaoheng
Lieber, Andre
McVey, John H.
Nicklin, Stuart A.
Baker, Andrew H.
机构
[1] Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Div Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland
[2] Univ London Imperial Coll Sci & Technol, Gene Therapy Res Grp, London, England
[3] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
[4] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London, England
基金
英国医学研究理事会;
关键词
KUPFFER CELLS LEADS; BINDING ABLATION; BLOOD; EXPRESSION; RECEPTOR; VECTORS; CAR; ACTIVATION; COXSACKIE; TOXICITY;
D O I
10.1182/blood-2006-04-008532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Upon local delivery, adenovirus (Ad) serotype 5 viruses use the coxsackie and Ad receptor (CAR) for cell binding and alpha(v) integrins for internalization. When administered systemically, however, their role in liver tropism is limited because CAR-permissive and mutated viruses show similar biodistribution, a finding recently attributed to blood coagulation factor (F) IX or complement protein C4BP binding to the adenovirus fiber and "bridging" to either low-density lipoprotein receptor-related protein or heparan sulfate proteoglycans. Here, we show that hepatocyte transduction in vitro can be enhanced by the vitamin K-dependent factors FX, protein C, and FVII in addition to FIX but not by prothrombin (FII), FXI, and FXII. This phenomenon was not dependent on proteolytic activation or cell signaling activity and for FX was mediated by direct virus-factor binding. Human FX substantially enhanced hepatocyte transduction by CAR-permissive and mutated viruses in an ex vivo liver perfusion model. In vivo, global down-regulation of vitamin K-dependent zymogens by warfarin significantly diminished liver uptake of CAR-deleted Ads; however, this phenomenon was fully rescued by acute infusion of human FX. Our results indicate a common and pivotal role for distinct vitamin K-dependent coagulation factors in mediating hepatocyte transduction by adenoviruses in vitro and in vivo.
引用
收藏
页码:2554 / 2561
页数:8
相关论文
共 36 条
  • [21] Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
    Raper, SE
    Chirmule, N
    Lee, FS
    Wivel, NA
    Bagg, A
    Gao, GP
    Wilson, JM
    Batshaw, ML
    [J]. MOLECULAR GENETICS AND METABOLISM, 2003, 80 (1-2) : 148 - 158
  • [22] A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells
    Schiedner, G
    Bloch, W
    Hertel, S
    Johnston, M
    Molojavyi, A
    Dries, V
    Varga, G
    Van Rooijen, N
    Kochanek, S
    [J]. HUMAN GENE THERAPY, 2003, 14 (17) : 1631 - 1641
  • [23] Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity Adenoviral vectors
    Schiedner, G
    Hertel, S
    Johnston, M
    Dries, V
    van Rooijen, N
    Kochanek, S
    [J]. MOLECULAR THERAPY, 2003, 7 (01) : 35 - 43
  • [24] The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors
    Schuettrumpf, J
    Zou, JX
    Zhang, Y
    Schlachterman, A
    Liu, YL
    Edmonson, S
    Xiao, WD
    Arruda, VR
    [J]. MOLECULAR THERAPY, 2006, 13 (01) : 88 - 97
  • [25] Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
    Shayakhmetov, DM
    Gaggar, A
    Ni, SH
    Li, ZY
    Lieber, A
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (12) : 7478 - 7491
  • [26] In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor
    Smith, T
    Idamakanti, N
    Kylefjord, H
    Rollence, M
    King, L
    Kaloss, M
    Kaleko, M
    Stevenson, SC
    [J]. MOLECULAR THERAPY, 2002, 5 (06) : 770 - 779
  • [27] Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates
    Smith, TAG
    Idamakanti, N
    Marshall-Neff, J
    Rollence, ML
    Wright, P
    Kaloss, M
    King, L
    Mech, C
    Dinges, L
    Iverson, WO
    Sherer, AD
    Markovits, JE
    Lyons, RM
    Kaleko, M
    Stevenson, SC
    [J]. HUMAN GENE THERAPY, 2003, 14 (17) : 1595 - 1604
  • [28] Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice
    Smith, TAG
    Idamakanti, N
    Rollence, ML
    Marshall-Neff, J
    Kim, J
    Mulgrew, K
    Nemerow, GR
    Kaleko, M
    Stevenson, SC
    [J]. HUMAN GENE THERAPY, 2003, 14 (08) : 777 - 787
  • [29] PRIMARY STRUCTURE OF THE VIRUS ACTIVATING PROTEASE FROM CHICK-EMBRYO - ITS IDENTITY WITH THE BLOOD-CLOTTING FACTOR-XA
    SUZUKI, H
    HARADA, A
    HAYASHI, Y
    WADA, K
    ASAKA, J
    GOTOH, B
    OGASAWARA, T
    NAGAI, Y
    [J]. FEBS LETTERS, 1991, 283 (02): : 281 - 285
  • [30] PLASMA PROTEIN-S IN DISSEMINATED INTRAVASCULAR COAGULATION, LIVER-DISEASE, COLLAGEN DISEASE, DIABETES-MELLITUS, AND UNDER ORAL ANTICOAGULANT-THERAPY
    TAKAHASHI, H
    TATEWAKI, W
    WADA, K
    SHIBATA, A
    [J]. CLINICA CHIMICA ACTA, 1989, 182 (02) : 195 - 208